LL-37 Research Lab Setup Guide

Setting up a research workflow around LL-37 is mostly a sourcing and documentation problem, not an equipment problem. You need monitored cold storage, low-binding consumables, a receiving process that reconciles every vial against its lot-specific certificate of analysis, written handling procedures, and a supplier whose purity and identity data you can verify before you place an order rather than after. For businesses buying at volume — med spas, clinics, telehealth operators, and resellers building a catalog — supplier qualification is the step that determines whether everything downstream holds together. All compounds discussed here are research use only and are not for human or veterinary use.

Why cathelicidin work demands tighter handling than the average peptide

LL-37 is a 37-residue peptide derived from the human cathelicidin precursor protein hCAP18. Research literature describes it as cationic and amphipathic, with a tendency to adopt helical structure under certain ionic and membrane-mimetic conditions. Studies indicate its behavior in solution is highly condition-dependent — salt concentration, pH, surface contact, and concentration itself all influence what happens in the tube.

That has practical consequences for a bench setup. Highly cationic peptides are known to adsorb onto standard plastic and glass surfaces, which means material can disappear from solution without any visible sign. Aggregation and freeze-thaw sensitivity are common concerns across this class. None of this is exotic, but it does mean that a lab running cathelicidin work needs to be more deliberate about consumables, temperature stability, and aliquoting discipline than a lab handling more forgiving compounds.

It also means your starting material matters more. If a lot arrives with variable purity, residual counterions, or moisture content that was never measured, you cannot separate compound variability from experimental variability. The setup guide, in other words, starts upstream of the lab.

The physical bench: what a workable setup actually requires

Start with cold storage that is monitored, not just cold. A freezer without continuous temperature logging and an alarm is a single point of failure that you will only discover after it has failed. Lyophilized and reconstituted material generally have different storage requirements, and your written procedure should distinguish them rather than treating all inventory the same way.

From there, the list is short but non-negotiable:

• Low-binding consumables. Low-retention tubes and pipette tips reduce surface adsorption losses that skew results with cationic peptides.
• A calibrated balance in a controlled space. Lyophilized peptide is hygroscopic and static-prone. Calibration records matter as much as the instrument.
• An aliquoting habit. Repeated freeze-thaw cycles are one of the most common and most avoidable sources of degradation. Single-use aliquots prepared once, on receipt, cost a little time and save a lot of ambiguity.
• Segregated, access-controlled storage. Research inventory should be physically and administratively separated from anything else your business holds, with a clear boundary between the two.
• Labeling that survives the freezer. Compound name, lot number, date received, date opened, storage condition, and a research-use-only statement on every container and aliquot.

Solvent selection, working concentrations, and preparation steps are determined by your own validated protocol and your institution's procedures — this is not the place for a generic recipe, and any supplier handing one out unprompted is telling you something about how they operate.

Documentation, receiving, and chain of custody

The part of a lab setup that most buyers under-build is the paper trail. It is also the part that becomes load-bearing the moment you are handling volume or reselling.

A functional receiving process does four things. It confirms the shipment arrived under the expected conditions. It reconciles the lot number printed on each vial against the packing slip and against the certificate of analysis — all three, not two of three. It records the receipt in an inventory log with date, quantity, lot, and storage location. And it triggers a documented deviation if any of those fail to match.

That last step is what separates a real process from a filing cabinet. A deviation record with no defined follow-up is decoration. Decide in advance who reviews mismatches, whether the lot is quarantined pending resolution, and what evidence closes the issue.

For resellers, chain of custody extends past your own shelves. If you cannot trace an outbound order back to a specific inbound lot and its COA, you have no way to scope a problem if one surfaces. Building that link into your inventory system at setup is straightforward. Retrofitting it later, across thousands of units, is not.

Retention is the final piece. Keep COAs, receiving records, temperature logs, and deviation files for a defined period set by your own policy and your counsel's guidance. Storing them in a supplier's customer portal is not retention — portals change and accounts lapse. Download and keep your own copies.

Reading a certificate of analysis without taking it on faith

A COA is only useful if it is lot-specific, legible, and complete. A generic document that describes the product rather than the batch in your hand tells you nothing about the material you actually received.

Two habits are worth building at setup. First, ask whether the COA is published openly or produced only on request — and whether it is bundled or sold as an add-on. Testing data that is gated, priced separately, or supplied only after purchase is a structural disincentive against scrutiny. Second, check that the chromatogram is actually attached and readable. A purity percentage typed onto a letterhead is a claim. A chromatogram is evidence.

Contrast that with the pattern you will encounter across parts of this industry: quote-only pricing, testing described in marketing copy but never shown, and certificates that carry no lot number. None of those are illegal. All of them shift risk onto you.

Supplier qualification: the questions that separate programs

Once the bench is sorted, procurement becomes the recurring work. The qualification questions below apply whether or not a specific compound is currently in a given supplier's catalog — the process is the same, and it is worth running before you commit to a partner rather than during a stockout.

Is pricing published or quote-gated? Published wholesale pricing lets you model a catalog before you talk to anyone. Quote-only pricing makes comparison across suppliers deliberately expensive in time.

Are COAs free, lot-specific, and independently viewable? You should be able to look at the lab results for the batch you are being offered before money moves.

How are tiers and minimums structured? Volume economics vary widely by compound and category, and any supplier quoting you universal margins is guessing. What matters is that the tier structure is written down, stable, and explained — not improvised per conversation.

Where does fulfillment originate, and how is lead time communicated? Domestic fulfillment shortens the loop between order and shelf. More importantly, a supplier that states its shipping window and holds to it is one you can plan inventory around.

What happens on reorder? Lot-to-lot consistency is the real test of a manufacturing relationship. Ask how variance between batches is handled and what documentation accompanies each one.

How is the material labeled? Research-use-only labeling should be present and unambiguous on arrival, not something you have to add yourself.

Regulatory questions that belong with your attorney

This section is informational and is not legal advice. The regulatory picture around research compounds is layered — federal frameworks, state professional board rules, business licensing, and labeling requirements can all apply, and they do not resolve into a single national answer.

Rather than assuming a position, bring specific questions to qualified counsel and your state board before you buy: How does my business entity's licensing status intersect with holding research inventory? What labeling and record-keeping obligations attach to what I intend to do? What does resale, as distinct from internal research use, change about my obligations? Are there state-level requirements that apply to my category of business specifically? Do my insurance and banking arrangements contemplate this activity?

General guidance found online — including this page — cannot answer those. Anyone who tells you the framework is simple has not read it, and a supplier who offers you a confident legal conclusion is doing something no supplier should do.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built for businesses that need to verify before they commit. Every compound in the catalog is produced to 99%+ HPLC purity and undergoes 7-panel batch testing, with results published as certificates of analysis that partners and prospective partners can review themselves — not paid extras, not documents released only after an order clears. That is the point: the verification step described throughout this guide is meant to be performed by you, on the actual lot data, before you decide.

Fulfillment runs domestically from the United States on a 5–7 day window, which makes inventory planning a calculation rather than a guess. Onboarding is a 3-step wholesale application rather than an open-ended sales cycle. All compounds are supplied for research use only and are not for human or veterinary use.

Putting procurement on the same footing as the bench

A lab setup is only as reliable as the material entering it. Monitored storage, low-binding consumables, single-use aliquots, and a receiving process that reconciles vial, packing slip, and lot-specific COA will carry most of the operational load. The remaining variable is the supplier — and that one is chosen, not managed. If your business is qualifying wholesale partners and you want to inspect purity and batch data before committing to a tier, the Real Peptides Wholesale Partner Program application is the next step, and the published COAs are available to review while you decide.

If your research interests extend beyond innate-immunity work, the same testing and documentation standards apply across the catalog — including epithelial-focused compounds such as KPV Peptide 10mg and the broader Gastrointestinal & Epithelial Research collection, tissue-signaling compounds like BPC-157 10mg and TB-500 10mg within Growth Factor & Tissue Signaling Research, and copper-complex compounds such as GHK-Cu 50mg.